Haematologica (Feb 2024)

<i>TP53</i> DNA binding domain mutational status and rituximab-based treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification

  • Gaia Martire,
  • Federica Lovisa,
  • Elisa Carraro,
  • Domenico Rizzato,
  • Simone Cesaro,
  • Rosa Maria Mura,
  • Annalisa Tondo,
  • Cinzia Bertolin,
  • Francesca Boaretto,
  • Leonardo Salviati,
  • Alessandra Biffi,
  • Marta Pillon,
  • Lara Mussolin

DOI
https://doi.org/10.3324/haematol.2023.284868
Journal volume & issue
Vol. 999, no. 1

Abstract

Read online

Not available.